WallStreetZenWallStreetZen

NASDAQ: AAPG
Ascentage Pharma Group International Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their AAPG stock forecasts and price targets.

Forecast return on equity

Is AAPG forecast to generate an efficient return?

Company
N/A
Industry
257.22%
Market
146.17%

Forecast return on assets

Is AAPG forecast to generate an efficient return on assets?

Company
N/A
Industry
109.18%

AAPG earnings per share forecast

What is AAPG's earnings per share in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
-$3.14
Avg 2 year Forecast
$2.37
Avg 3 year Forecast
-$0.75

AAPG revenue forecast

What is AAPG's revenue in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
$598.1M+1,000.99%
Avg 2 year Forecast
$2.8B+5,059.6%
Avg 3 year Forecast
$1.9B+3,321.94%
AAPG's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AAPG revenue growth forecast

How is AAPG forecast to perform vs Biotechnology companies and vs the US market?

Company
252.55%
Industry
108.19%
Market
25.27%
AAPG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AAPG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AAPG vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AAPG$33.40N/AN/A
IRON$85.00$109.25+28.53%Strong Buy
TARS$67.52$74.33+10.09%Buy
KNSA$37.38$51.33+37.33%Strong Buy
IDYA$32.18$48.00+49.16%Strong Buy
View Top Biotech Stocks

Ascentage Pharma Group International Stock Forecast FAQ

What is AAPG's earnings growth forecast for 2025-2027?

(NASDAQ: AAPG) Ascentage Pharma Group International's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 26.43%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 40.98%.

Ascentage Pharma Group International's earnings in 2025 is -$161,448,746.On average, 10 Wall Street analysts forecast AAPG's earnings for 2025 to be -$1,096,067,264, with the lowest AAPG earnings forecast at -$1,282,572,501, and the highest AAPG earnings forecast at -$861,155,822. On average, 10 Wall Street analysts forecast AAPG's earnings for 2026 to be $827,616,987, with the lowest AAPG earnings forecast at -$280,455,854, and the highest AAPG earnings forecast at $1,689,331,208.

In 2027, AAPG is forecast to generate -$261,121,291 in earnings, with the lowest earnings forecast at -$820,846,401 and the highest earnings forecast at $1,201,953,658.

If you're new to stock investing, here's how to buy Ascentage Pharma Group International stock.

What is AAPG's revenue growth forecast for 2025-2027?

(NASDAQ: AAPG) Ascentage Pharma Group International's forecast annual revenue growth rate of 252.55% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 108.19%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.27%.

Ascentage Pharma Group International's revenue in 2025 is $54,401,532.On average, 10 Wall Street analysts forecast AAPG's revenue for 2025 to be $208,743,473,278, with the lowest AAPG revenue forecast at $174,209,990,564, and the highest AAPG revenue forecast at $267,507,978,780. On average, 10 Wall Street analysts forecast AAPG's revenue for 2026 to be $978,245,093,960, with the lowest AAPG revenue forecast at $624,010,784,160, and the highest AAPG revenue forecast at $1,196,718,668,280.

In 2027, AAPG is forecast to generate $648,789,735,880 in revenue, with the lowest revenue forecast at $352,140,313,880 and the highest revenue forecast at $1,107,025,843,040.

What is AAPG's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: AAPG) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 109.18%.

What is AAPG's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: AAPG) Ascentage Pharma Group International's current Earnings Per Share (EPS) is -$2.02. On average, analysts forecast that AAPG's EPS will be -$3.14 for 2025, with the lowest EPS forecast at -$3.68, and the highest EPS forecast at -$2.47. On average, analysts forecast that AAPG's EPS will be $2.37 for 2026, with the lowest EPS forecast at -$0.80, and the highest EPS forecast at $4.84. In 2027, AAPG's EPS is forecast to hit -$0.75 (min: -$2.35, max: $3.44).

What is AAPG's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: AAPG) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.